Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
(NASDAQ: AKTS) Delayed: 21.93 +2.47 (12.69%)
Previous Close $19.46    52 Week High $5.77 
Open $21.36    52 Week Low $1.51 
Day High $22.60    P/E N/A 
Day Low $20.96    EPS $0.00 
Volume 848,611